Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows
byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos
Updated on: December 01,2024
0

Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows
byUppsala UniversityA graphical summary illustrates the strategy used to identify CYP2D6 as a target for collateral lethality, which is driven by the widespread occurrence of loss of heterozygos
Updated on:December 01,2024
0
